Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Sign Up to like & getrecommendations! Published in 2017 at "Swiss medical weekly"
DOI: 10.4414/smw.2017.14544
Abstract: BACKGROUND In Switzerland, intravenous drug use accounts for the majority of hepatitis C virus (HCV) infections. Early HCV treatment prevents further transmissions and reduces morbidity and mortality due to decompensated liver cirrhosis and hepatocellular carcinoma.… read more here.
Keywords: drug substitution; hiv; treatment; hcv ... See more keywords
Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over.
Sign Up to like & getrecommendations! Published in 2017 at "Swiss medical weekly"
DOI: 10.4414/smw.2017.14570
Abstract: More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and integrating HCV services. read more here.
Keywords: hepatitis treatment; drug substitution; treatment patients; substitution programmes ... See more keywords
Drug substitution and adjuvant therapy in patients with genetics related infertility: A review.
Sign Up to like & getrecommendations! Published in 2023 at "Drug discoveries & therapeutics"
DOI: 10.5582/ddt.2022.01096
Abstract: With the in-depth study of the human genome and the increasing popularity of gene sequencing, it has been gradually confirmed that genetics can play a crucial role in infertility. To provide references for clinical treatment,… read more here.
Keywords: adjuvant therapy; infertility review; infertility; drug substitution ... See more keywords